Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The British Journal of Dermatology|October 13, 2009
Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndromeL Fardet, L Galicier, M-D Vignon-Pennamen, et al.
Annales De Dermatologie Et De Venereologie|October 5, 2019
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]A Seris, M Battistella, M Beylot-Barry, et al.
ESMO Open|October 29, 2021
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-upS P D'Angelo, S Bhatia, A S Brohl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Transplantation|May 26, 1999
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF)D Farge, C Lebbé, Z Marjanovic, et al.
British Journal of Cancer|January 22, 2004
Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanomaN Soufir, J J Lacapere, G Bertrand, et al.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
Annales De Dermatologie Et De Venereologie|April 18, 2018
Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016C Hurabielle, M Battistella, C Ram-Wolff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox studyJ-M L'Orphelin, J Cassecuel, L Kandolf, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2024
Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patientsC Robert, G V Long, J Larkin, et al.
Pageof 7